BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24458079)

  • 41. Treating hypertension to reduce cardiovascular risk: a Korean perspective.
    Kim KI; Kim CH
    Clin Ther; 2012 Jul; 34(7):1559-68. PubMed ID: 22704810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applying the new intensive blood pressure categories to a nondialysis chronic kidney disease population: the Prevalence, Awareness and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China survey.
    Zheng Y; Tang L; Zhang W; Zhao D; Zhang D; Zhang L; Cai G; Chen X;
    Nephrol Dial Transplant; 2020 Jan; 35(1):155-161. PubMed ID: 30304540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.
    Cooney D; Moon H; Liu Y; Miller RT; Perzynski A; Watts B; Drawz PE
    BMC Nephrol; 2015 Apr; 16():56. PubMed ID: 25881226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort study.
    Hoshino J; Nagai K; Kai H; Saito C; Ito Y; Asahi K; Kondo M; Iseki K; Iseki C; Okada H; Kashihara N; Narita I; Wada T; Combe C; Pisoni RL; Robinson BM; Yamagata K
    Clin Exp Nephrol; 2018 Apr; 22(2):309-317. PubMed ID: 28741051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease.
    Koutroumpakis E; Gosmanova EO; Stahura H; Jou S; Alreshq R; Ata A; Sidhu MS; Philbin E; Boden WE; Lyubarova R
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):443-451. PubMed ID: 31123935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia, and associated risk factors in the Czech Republic, Russia, Poland and Lithuania: a cross-sectional study.
    Lu W; Pikhart H; Tamosiunas A; Kubinova R; Capkova N; Malyutina S; Pająk A; Bobak M
    BMC Public Health; 2022 May; 22(1):883. PubMed ID: 35508994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf.
    Al-Zakwani I; Al-Mahmeed W; Arafah M; Al-Hinai AT; Shehab A; Al-Tamimi O; Al-Awadhi M; Al-Herz S; Al-Anazi F; Al-Nemer K; Metwally O; Al-Khadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al-Jassim O; Al-Hallaq O; Baslaib FO; Amin H; Santos RD; Al-Waili K; Al-Hashmi K; Al-Rasadi K
    Curr Vasc Pharmacol; 2016; 14(4):374-81. PubMed ID: 26496982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes and Hypertension: A Comparative Review of Current Guidelines.
    Cryer MJ; Horani T; DiPette DJ
    J Clin Hypertens (Greenwich); 2016 Feb; 18(2):95-100. PubMed ID: 26234374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: The China Health and Retirement Longitudinal Study.
    Wang S; Chen R; Liu Q; Shu Z; Zhan S; Li L
    Nephrology (Carlton); 2015 Jul; 20(7):474-84. PubMed ID: 25773384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg.
    Lee YH; Lee SG; Lee MH; Kim JH; Lee BW; Kang ES; Lee HC; Cha BS
    J Am Heart Assoc; 2014 Feb; 3(1):e000650. PubMed ID: 24572249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CKD risk factors reported by primary care physicians: do guidelines make a difference?
    Lea JP; McClellan WM; Melcher C; Gladstone E; Hostetter T
    Am J Kidney Dis; 2006 Jan; 47(1):72-7. PubMed ID: 16377387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study.
    Lo C; Ilic D; Teede H; Cass A; Fulcher G; Gallagher M; Johnson G; Kerr PG; Mathew T; Murphy K; Polkinghorne K; Walker R; Zoungas S
    PLoS One; 2016; 11(1):e0146615. PubMed ID: 26730708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
    Yan Z; Wang Y; Li S; Wang J; Zhang L; Tan H; Li S; Yang L; Pei H; Zhang L; Wang Y; Duan J; Jiao S; Zhao M; Fu S;
    Am J Hypertens; 2018 Mar; 31(4):486-494. PubMed ID: 29304216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of cardiovascular risk factors among 28,000 employees.
    Scheerbaum M; Langenbach C; Scheerbaum P; Heidemann F; Rieß HC; Heigel H; Debus SE; Behrendt CA
    Vasa; 2017 May; 46(3):203-210. PubMed ID: 28156256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of Chronic Kidney Disease Management in Canadian Primary Care.
    Bello AK; Ronksley PE; Tangri N; Kurzawa J; Osman MA; Singer A; Grill AK; Nitsch D; Queenan JA; Wick J; Lindeman C; Soos B; Tuot DS; Shojai S; Brimble KS; Mangin D; Drummond N
    JAMA Netw Open; 2019 Sep; 2(9):e1910704. PubMed ID: 31483474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
    Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
    Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study.
    Abdel-Kader K; Greer RC; Boulware LE; Unruh ML
    BMC Nephrol; 2014 Apr; 15():64. PubMed ID: 24755164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kidney health for everyone everywhere - from prevention to detection and equitable access to care.
    Li PK; Garcia-Garcia G; Lui SF; Andreoli S; Fung WW; Hradsky A; Kumaraswami L; Liakopoulos V; Rakhimova Z; Saadi G; Strani L; Ulasi I; Kalantar-Zadeh K;
    Saudi J Kidney Dis Transpl; 2020; 31(2):298-311. PubMed ID: 32394902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.